Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dexcom Inc (DXCM)

Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dexcom Inc 6340 SEQUENCE DRIVE SAN DIEGO CA 92121 USA

www.dexcom.com Employees: 11,000 P: 858-200-0200

Sector:

Medical

Description:

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.

Key Statistics

Overview:

Market Capitalization, $K 27,814,192
Enterprise Value, $K 28,137,392
Shares Outstanding, K 384,865
Float, K 383,633
% Float 99.68%
Short Interest, K 15,503
Short Float 4.03%
Days to Cover 2.58
Short Volume Ratio 0.46
% of Insider Shareholders 0.32%
% of Institutional Shareholders 97.75%

Financials:

Annual Sales, $ 4,662 M
Annual Net Income, $ 836,300 K
Last Quarter Sales, $ 1,260 M
Last Quarter Net Income, $ 267,300 K
EBIT, $ 911,800 K
EBITDA, $ 1,164 M

Growth:

1-Year Return -18.80%
3-Year Return -34.35%
5-Year Return -27.33%
5-Year Revenue Growth 141.97%
5-Year Earnings Growth 167.95%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.68 on 02/12/26
Next Earnings Date 05/07/26
Earnings Per Share ttm 2.09
EPS Growth vs. Prev Qtr 11.48%
EPS Growth vs. Prev Year 51.11%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 4-1 on 06/13/22

DXCM Ratios

Ratio
Price/Earnings ttm 34.83
Price/Earnings forward 29.19
Price/Earnings to Growth 1.42
Return-on-Equity % 32.12%
Return-on-Assets % 11.86%
Profit Margin % 17.94%
Debt/Equity 0.45
Price/Sales 6.01
Price/Cash Flow 26.29
Price/Book 10.34
Book Value/Share 7.04
Interest Coverage -1.84
60-Month Beta 1.49
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar